Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.K. (FTSE) Market Analysis & Valuation

UpdatedJul 22, 2026
DataAggregated Company Financials
Companies1083
  • 7D0.6%
  • 3M0.5%
  • 1Y16.7%
  • YTD6.2%

In the last week, the market has been flat. As for the longer term, the market has risen 17% in the past 12 months. Looking forward, earnings are forecast to grow by 11% annually.

Trending IndustriesOil and GasGoldBiotechSoftwareRenewable Energy

Market Valuation and Performance

Has the U.K. Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 22 Jul 2026UK£3.0tUK£2.0tUK£165.0b15.8x18x1.5x
Fri, 19 Jun 2026UK£2.9tUK£2.0tUK£165.6b16x17.7x1.4x
Sun, 17 May 2026UK£2.9tUK£2.0tUK£165.4b15.7x17.5x1.4x
Tue, 14 Apr 2026UK£3.0tUK£2.0tUK£157.2b15.8x19x1.5x
Thu, 12 Mar 2026UK£2.9tUK£2.0tUK£155.2b16x18.9x1.5x
Sat, 07 Feb 2026UK£3.0tUK£1.9tUK£140.7b16.9x21.1x1.5x
Mon, 05 Jan 2026UK£2.8tUK£2.0tUK£138.0b16.3x20.6x1.5x
Wed, 03 Dec 2025UK£2.8tUK£2.0tUK£139.9b16.2x20.1x1.4x
Fri, 31 Oct 2025UK£2.8tUK£2.0tUK£137.6b16.5x20.4x1.4x
Sun, 28 Sep 2025UK£2.7tUK£1.9tUK£135.9b16.6x19.7x1.4x
Tue, 26 Aug 2025UK£2.7tUK£1.9tUK£134.1b16.1x20.1x1.4x
Thu, 24 Jul 2025UK£2.6tUK£1.9tUK£126.9b16.1x20.1x1.3x
Sat, 21 Jun 2025UK£2.5tUK£1.9tUK£127.6b16.4x19.5x1.3x
Mon, 19 May 2025UK£2.5tUK£2.0tUK£133.0b16.5x18.6x1.3x
Wed, 16 Apr 2025UK£2.3tUK£2.0tUK£134.8b15.2x17.4x1.2x
Fri, 14 Mar 2025UK£2.4tUK£2.0tUK£137.3b15x17.8x1.2x
Sun, 09 Feb 2025UK£2.5tUK£2.0tUK£123.9b16x20.3x1.2x
Tue, 07 Jan 2025UK£2.4tUK£2.0tUK£123.0b15.9x19.7x1.2x
Thu, 05 Dec 2024UK£2.4tUK£2.0tUK£122.6b16.4x20x1.2x
Sat, 02 Nov 2024UK£2.4tUK£2.0tUK£118.3b16.3x20.4x1.2x
Mon, 30 Sep 2024UK£2.5tUK£2.0tUK£117.8b17x20.8x1.2x
Wed, 28 Aug 2024UK£2.5tUK£2.0tUK£119.2b17x20.6x1.2x
Fri, 26 Jul 2024UK£2.4tUK£2.0tUK£129.7b16.3x18.6x1.2x
Sun, 23 Jun 2024UK£2.4tUK£2.0tUK£132.0b16.7x18.4x1.2x
Tue, 21 May 2024UK£2.5tUK£2.0tUK£125.5b17.2x20.1x1.2x
Thu, 18 Apr 2024UK£2.4tUK£2.1tUK£148.3b15.7x16x1.1x
Sat, 16 Mar 2024UK£2.3tUK£2.0tUK£144.3b16.1x16.1x1.1x
Mon, 12 Feb 2024UK£2.3tUK£2.0tUK£144.7b15.2x15.6x1.1x
Wed, 10 Jan 2024UK£2.3tUK£2.1tUK£193.5b15x12x1.1x
Fri, 08 Dec 2023UK£2.3tUK£2.1tUK£193.9b14.7x11.7x1.1x
Sun, 05 Nov 2023UK£2.2tUK£2.1tUK£193.8b14x11.6x1x
Tue, 03 Oct 2023UK£2.3tUK£2.2tUK£186.7b14.3x12.5x1.1x
Thu, 31 Aug 2023UK£2.3tUK£2.1tUK£183.3b14.5x12.6x1.1x
Sat, 29 Jul 2023UK£2.4tUK£2.1tUK£191.6b14.3x12.5x1.1x
Price to Earnings Ratio

12.5x


Total Market Cap: UK£2.4tTotal Earnings: UK£191.6bTotal Revenue: UK£2.1tTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Market Price to Earnings3Y Average 17.8x202420252026
Current Market PE
  • Investors are relatively neutral on the British market at the moment, indicating that they expect earnings will grow in line with historical growth rates.
  • The market is trading close to its 3-year average PE ratio of 17.8x.
Past Earnings Growth
  • The earnings for British listed companies have declined 4.9% per year over the last three years.
  • Meanwhile revenues have been flat.
  • This means that either the cost of doing business or the level of investment back into businesses is increasing since sales have remained steady while profits have fallen.

Sector Trends

Which sectors have driven the changes within the U.K. Market?

GB Market0.56%
Energy2.81%
Consumer Staples2.04%
Real Estate1.27%
Industrials1.24%
Healthcare0.55%
Consumer Discretionary0.50%
Financials0.42%
Tech0.26%
Utilities-1.52%
Telecom-1.98%
Materials-2.31%
Sector PE
  • Investors favour the Tech sector the most for future growth, which is trading close to its 3-year average PE ratio of 51.4x.
    • The market's confidence is likely because analysts are expecting annual earnings growth of 17.7%, which is higher than its past year's earnings growth of 7.7% per year.
  • The Financials sector is the least preferred by investors for future growth. Although, investor sentiment seems to have improved given that it's trading above its 3-year average of 10.3x.
Forecasted Growth
  • Analysts are most optimistic on the Telecom sector, expecting annual earnings growth of 26% over the next 5 years.
  • This is better than its past earnings decline of 1.8% per year.
  • In contrast, the Energy sector is expected to see its earnings grow by 6.6% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
SHEL ShellUK£32.543.4%
+UK£5.8b		24.2%PE12.9xEnergy
BATS British American TobaccoUK£46.055.1%
+UK£4.8b		19.5%PE12.9xConsumer Staples
HSBA HSBC HoldingsUK£15.091.3%
+UK£3.3b		59.9%PB1.8xFinancials
NWG NatWest GroupUK£6.794.5%
+UK£2.3b		35.7%PB1.2xFinancials
AZN AstraZenecaUK£124.921.0%
+UK£2.0b		20.7%PE25xHealthcare
See more

Market Insights

Header cover image
A strong brand today doesn't guarantee a strong brand forever. Even the most established names can see their pricing power fade over time. In an industry landscape being reshaped by new entrants, shifting tastes and disruptive technology, it's worth understanding how to tell a temporary dip from a permanent decline.
Continue reading
What makes a lasting brand?

Latest News

SHEL
UK£32.54
Shell
7D
3.4%
1Y
24.2%
RR.
UK£13.73
Rolls-Royce Holdings
7D
-2.1%
1Y
39.6%
ROR
UK£4.85
Rotork
7D
68.2%
1Y
50.8%
ANTO
UK£36.67
Antofagasta
7D
-4.6%
1Y
84.0%
Narrative Update • Jul 21

ANTO: Execution Risks Around 2026 Copper Output Will Restrain Upside Potential

The latest Narrative Update on Antofagasta reflects a modest reduction in the analyst price target fair value estimate to £25.74 from £26.50, as analysts factor in slightly slower revenue growth assumptions, a higher discount rate and a lower future P/E multiple, partly offset by firmer profit margin expectations. Analyst Commentary Recent Street research on Antofagasta shows a wide range of opinions on the stock, with some firms highlighting potential upside and others flagging valuation and execution risks.
LSEG
UK£86.00
London Stock Exchange Group
7D
-4.2%
1Y
-18.5%
HSBA
UK£15.09
HSBC Holdings
7D
1.3%
1Y
59.9%
Narrative Update • Jul 21

HSBA: Tighter Private Credit Lending Will Eventually Restrain Future Earnings Power

Analysts have raised their price target on HSBC Holdings to £9.97 from £7.73. They cite updated assumptions on fair value, a lower discount rate, modestly higher revenue growth and profit margin forecasts, and a slightly higher future P/E multiple.
GSK
UK£18.93
GSK
7D
-1.4%
1Y
40.5%
BP.
UK£5.29
BP
7D
2.5%
1Y
31.4%
NWG
UK£6.79
NatWest Group
7D
4.5%
1Y
35.7%
Narrative Update • Jul 17

NWG: Structural Hedge Reinvestment And Buybacks Will Drive Future Upside Re Rating

NatWest Group's analyst price target has been nudged higher to around £7.61 from about £7.44, with analysts pointing to updated assumptions on fair value, discount rate and P/E alongside recent target increases and ratings support from several banks. Analyst Commentary Recent research on NatWest Group highlights a split between more optimistic analysts, who see room for the shares to reflect higher fair value, and more cautious voices, who are focused on execution and sector level risks.
BA.
UK£19.09
BAE Systems
7D
3.0%
1Y
2.7%
RIO
UK£67.73
Rio Tinto Group
7D
-2.6%
1Y
43.7%
Narrative Update • Jul 16

RIO: Iron Ore And Copper Project Execution Will Support Future Upside

The analyst price target for Rio Tinto Group has been trimmed by £2.10, as analysts factor in slightly higher discount rates, more cautious revenue growth assumptions, and recent shifts in sentiment around valuation and key commodity fundamentals. Analyst Commentary Recent research on Rio Tinto Group shows a mix of caution and optimism, with price targets adjusted in both directions as analysts reassess valuation, commodity exposure and project execution.
AZN
UK£124.92
AstraZeneca
7D
1.0%
1Y
20.7%
Narrative Update • Jul 16

AZN: Trial Setbacks And Oncology Deals Will Shape Medium Term Credibility

AstraZeneca's updated analyst price targets show a modest reset lower, with recent research pointing to greater uncertainty around medium term revenue catalysts and mixed trial outcomes, even as some analysts continue to highlight areas of support within the broader pipeline and existing portfolio. Analyst Commentary Recent research on AstraZeneca highlights a mix of caution and support, with several firms revisiting their models after the CARDIO TTRansform outcome and reassessing how much risk investors are taking on around the medium term growth story.
AAL
UK£34.78
Anglo American
7D
-5.2%
1Y
48.6%
Narrative Update • Jul 15

AAL: Copper Shift And Chile Projects Will Drive Future Rerating

Analysts have nudged the fair value estimate for Anglo American slightly lower to around £48 from about £50, even as external price targets have been raised into the £33.50 to £45.00 range. They cite a mix of higher assumed revenue growth, modestly softer profit margins, and ongoing cost and freight risks in key iron ore markets, balanced against stronger copper driven expectations.
NG.
UK£12.24
National Grid
7D
-2.0%
1Y
12.9%
BATS
UK£46.05
British American Tobacco
7D
5.1%
1Y
19.5%
III
UK£25.03
3i Group
7D
-5.2%
1Y
-41.5%